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Abstract 
A sufficient supply molecular oxygen is essential for the maintenance of physiologic 
metabolism and bioenergetic homeostasis for most metazoans. For this reason, mechanisms 
have evolved for eukaryotic cells to adapt to conditions where oxygen demand exceeds 
supply (hypoxia). These mechanisms rely on the modification of pre-existing proteins, 
translational arrest and transcriptional changes. The hypoxia inducible factor (HIF; a master 
regulator of gene induction in response to hypoxia) is responsible for the majority of induced 
gene expression in hypoxia. However, much less is known about the mechanism(s) 
responsible for gene repression, an essential part of the adaptive transcriptional response. 
Hypoxia-induced gene repression leads to a reduction in energy demanding processes and the 
redirection of limited energetic resources to essential housekeeping functions. Recent 
developments have underscored the importance of transcriptional repressors in cellular 
adaptation to hypoxia. To date, at least ten distinct transcriptional repressors have been 
reported to demonstrate sensitivity to hypoxia. Central among these is the Repressor Element-
1 Silencing Transcription factor (REST), which regulates over 200 genes. In this review, 
written to honor the memory and outstanding scientific legacy of Lorenz Poellinger, we 
provide an overview of our existing knowledge with respect to transcriptional repressors and 
their target genes in hypoxia.  
 
Keywords: Hypoxia, Repressor, Transcription, REST 
 
1- The activation and resolution of adaptive responses to hypoxia. 
 
The evolution of mitochondrial respiration along with the associated increase in cellular 
metabolic capacity, allowed the development of multicellular organisms
1
. Oxygen, the final 
electron acceptor in the oxidation of organic compounds, is thus essential to sustain 
essentially all complex life. Hypoxia is the condition which arises when metabolic oxygen 
demand exceeds it’s supply. Exposure to hypoxia can elicit adaptation, such as that observed 
during ascent to high altitude, where erythropoiesis is induced to counteract the reduced 
atmospheric oxygen supply
2
.  
Hypoxia is commonly associated with a range of pathophysiological states including 
ischemia, chronic inflammatory disease and cancer
3
. Taking inflammatory diseases as an 
example, upon tissue invasion by a pathogen, resident and recruited inflammatory cells mount 
a protective response that requires the oxygen-demanding synthesis of inflammatory 
mediators and oxidative burst therefore creating a hypoxic environment
4
. When inflammation 
chronic, the associated fibrosis and thrombosis also results in diminished blood delivery, thus 
exacerbating the hypoxic state
5
. Physiological hypoxic microenvironments are also common 
and can occur in the developing embryo and the adult
3
. Hypoxic regions arise in a spatio-
temporally controlled way in the developing embryo and function as signal to orchestrate 
embryonic development
6,7
. Physiological hypoxia is also important in the adult where 
hematopoietic stem cells reside in the most hypoxic niches of the bone marrow
8,9
. Therefore, 
hypoxia is a relatively commonly encountered threat to the maintenance of metabolic 
homeostasis in health and disease. 
Adaptation to hypoxia involves 3 major responses (Figure 1): (1) increased glycolysis to cope 
with ATP depletion, (2) increased oxygen delivery to restore oxidative phosphorylation, and 
(3) inhibition of energy-demanding processes, to direct the scarce energetic resources to key 
house-keeping functions. This can be achieved by acute responses that rely on the 
modification of pre-existing proteins, translational inhibition and transcriptional changes 
(Figure 1) that a will be discussed in detail in the next sections. 
 
1.1-Modulation of the activity of pre-existing proteins 
The strategies used by a cell to adapt to hypoxia are dependent upon the extent and duration 
of the challenge. Acute hypoxia can induce rapid and transient effects on the activity of pre-
existing proteins
10
.  This can be achieved through the regulation of post-translational 
modifications such as hydroxylation
11-13
 and phosphorylation
14
, or through a direct effect on 
enzymes that requires oxygen such haem oxygenase-2 (HO-2). HO-2 activity is reduced in 
the carotid bodies in response to systemic hypoxia, leading to the modulation of ion channel 
activity and the subsequent generation of neuronal signals that promote increased depth and 
rate of breathing to restore systemic oxygen levels to normal
15
. Finally, hypoxia-induced 
changes in cellular metabolism can indirectly affect enzyme activity. For example, the AMP-
activated protein kinase (AMPK), a sensor of AMP:ATP ratios, is activated when ATP levels 
drop in response to hypoxia, and promotes energetic homeostasis by activating catabolic 
process and inhibiting anabolic metabolism
16,17
. While the acute responses to hypoxia are 
mostly mediated by changes in the activity of pre-existing proteins, long lasting adaptation to 
chronic hypoxia (e.g. high altitude) is achieved through delayed, yet sustained, changes in 
translation and transcription.  
 
1.2-Inhibition of translation 
Down-regulation of energy consuming processes under hypoxic conditions is thought to be 
part of an energetic adaptation strategy, aimed at redirecting the available energy supply 
(ATP) to house-keeping functions, especially the maintenance of ionic and osmotic 
homeostasis in order to prevent membrane depolarization and subsequent cell swelling and 
necrosis
18
. Protein translation is one of the most energy consuming processes that occurs in 
cells. In rat cardiomyocytes it can take up to 27% of the total cellular energy capacity. RNA 
synthesis and Na+/K+ ATPase activity are the two other major energy sinks under normoxic 
conditions taking 20% and 22% of total energy capacity, respectively
19
. When energy 
capacity is reduced, translational rates are among the first cellular processes to be down-
regulated.
20-22
 Hypoxia induces translational arrest by activation of PERK and inhibition of 
mTOR, two major modulators of the translational machinery
22,23
. Therefore, by reducing the 
rate of protein translation in hypoxia, energy is conserved and reserved for essential  
processes. 
 
1.3-Transcriptional adaptation 
1.3.1-Gene induction in hypoxia 
The discovery of the hypoxia inducible factor (HIF)
24,25
 opened the way to the study of 
transcriptional regulation as a means for adaptation to hypoxia. HIF is responsible for 
adaptation to hypoxia through mechanisms including the induction of angiogenesis and 
erythropoiesis. HIF promotes such adaptive processes through the induction of VEGF and 
EPO respectively.  HIF also promotes an increase in glycolysis to compensate for loss of ATP 
production during oxidative phosphorylation, through the induction of many of the enzymes 
in the glycolytic pathway (e.g. LDHA), and also through the induction of PDK1, which 
inhibits the conversion of pyruvate to acetyl Coenzyme A and entry into the tricarboxylic acid 
cycle
26
.  
The HIF pathway evolved as an adaptive mechanism, but it is maladaptive in cancer, where it 
plays an oncogenic role through the up-regulation of numerous genes that promote tumor 
growth. For example, increased glycolysis is thought to facilitate diversion of glycolytic 
intermediates into nucleoside and amino acid biosynthetic pathways facilitating cellular 
proliferation
27
, and increased expression of the collagen remodeling LOX genes promotes 
metastasis
28
. While HIF is the master regulator of gene induction in hypoxia (transcriptomic 
studies have revealed that HIF regulates 29% to 52% of induced genes
29-31
), other 
transcription factors also contribute to the full-spectrum of transcriptional changes. Indeed, at 
least 20 other transcriptional activators are known to be regulated by hypoxia (Table S1)
32
.   
A fundamental aspect of the HIF response is its resolution, which is necessary to prevent 
detrimental effects on cells and tissues, including tissue acidification, increased haematocrit
33-
35
 and chronic HIF stabilization which has been associated with a number of cancers
33
. An 
example of a non-resolving HIF response is causative in the von Hippel-Lindau (VHL) 
disease, a hereditary human cancer syndrome predisposing patients to highly angiogenic 
tumours
36
. In these patients loss of VHL causes HIF stabilization under normoxic conditions 
and expression of tumor promoting HIF target genes
36
.  
 
1.3.2-Gene repression in hypoxia 
It is clear form transcriptomic studies that in response to hypoxia, concomitant with 
transcriptional up-regulation, there is transcriptional repression of comparable numbers of 
genes (Table S2). The mechanisms underpinning transcriptional repression is poorly 
understood relative to gene induction where HIF transcription factors are of central 
importance. Nonetheless transcriptional gene repression in hypoxia are a central part of the 
overall adaptive transcriptional response, as illustrated by the common repression between 
different transcriptional studies of several gene families involved in energy-demanding 
processes such as transcription, translation, mRNA processing and splicing, cell cycle and 
proliferation (Table S3). Hypoxia-repressed (but not hypoxia-induced) in vitro derived 
transcriptional signatures have prognostic value in breast cancer
37
. This fact alone highlights 
the need for a better understanding of the mechanisms of gene repression in hypoxia. The 
clinical importance of hypoxia-repressed genes has not been as thoroughly investigated as the 
importance of induced genes. This historical bias is probably influenced by the large amount t 
of attention focused on the HIF pathway  which regulates the transcriptional induction of 
hundreds of target genes
37
.  
Transcriptional down-regulation of these energy-demanding processes under hypoxic 
conditions might be an essential part of a defense mechanism to direct the scarce energy 
available to essential house-keeping functions
18
. As described above, protein translation is 
regulated by hypoxia due to the action of the mTOR and PERK (Figure 1). However, long-
term changes in translation and determined at the transcriptional level, likely so that the cells 
don’t waste valuable resource in making new RNA that cannot be translated into protein due 
to the energy deficit. Consistent with this notion, genes related to translation are among the 
ones most commonly found to be repressed in transcriptomic studies (Table S3). For 
example, the translation initiation factor EIF5A is one of the five most down-regulated genes 
in hypoxia (>6 fold)
31
. 
Most transcriptomic studies measure steady state mRNA level, but changes in mRNA 
stability influence the expression levels.  Transcriptomic studies on the effect of hypoxia on 
de novo (nascent) mRNA pools revealed 196 differentially expressed genes, 43 of which 
where repressed in RAW264.7 macrophages
38
. In another study performed in kidneys from 
ischemic mice, 1219 genes were differentially expressed (642 up- and 577 down-regulated), 
combinatorial analysis of steady state and nascent mRNA revealed that the majority of the 
genes (947) where de facto transcriptional changes rather than mRNA 
stabilization/destabilization
39
. Thus, gene repression in hypoxia is at least in part mediated by 
de facto transcriptional changes, resulting from the activation of transcriptional repressors.  
A better understanding of the mechanism leading to repression of the genes involved in 
multiple energy-demanding processes (Table S3), would allow a better understanding of the 
adaptation to hypoxia, and potentially new avenues for therapeutic intervention. In this review 
we aim to provide an overview of the known existing mechanisms for transcriptional gene 
repression in hypoxia mediated by the activation of transcriptional repressors, an area that has 
been much less under the scrutiny of the scientific community, than gene induction in 
hypoxia and its master regulator HIF. Initially we will focus on REST, a transcriptional 
repressor that has been implicated by several studies to be a key transcription factor in 
hypoxia, and possibly a master regulator of gene repression
40
.  
 
2-Mechanisms of transcriptional repression in hypoxia 
Transcriptional repressors are a large and diverse group of proteins
41
. They can repress 
transcription through one, or a combination of several mechanisms: inhibition of the basal 
transcriptional machinery, inhibition of transcriptional activators or remodeling of chromatin 
structure
41
. Repressors play essential roles in physiology, from embryonic development
42,43
 to  
adaptation to stress
44
, and pathophysiology from neurological disorders
44
 to cancer
45
. Hypoxia 
is a major stress to the cells, that requires gene repression for adaptation. In the following 
sections we will summarize existing evidence for roles plays by transcriptional repressors in 
hypoxia. 
 
2.1-The Repressor Element 1-Silencing Transcription Factor (REST) 
      also  nown as neu on  est   t ve s len e   a to           s a     - o    u ppel-type 
zinc finger, one of the largest classes of transcription factors in humans
46
. REST is recruited 
to target genes containing the 21 base pair Repressor Element 1 (RE1), and inhibits 
transcription by interaction with the basal transcriptional machinery or by regulation of 
chromatin structure
42
. REST was originally discovered as a master regulator of neuronal 
development
47,48
, and is the first example of a transcriptional repressor that regulates a large 
repertoire of cell-type specific genes
49
. During embryonic development, neuronal precursor 
cells gradually loose REST expression through proteasomal degradation, as a result, REST 
target genes are expressed in mature neurons, conferring them their unique phenotype, while 
repressing it everywhere else
42
. 
Several lines of evidence indicate that the simple picture of REST being a neuronal switch, is 
far more complex, with REST being expressed in some neurons within the brain, where it 
serves a neuro-modulatory role, in response to stimuli including seizure
50,51
, ischemia
52,53
, 
oxidative stress and ageing
44
. In addition, in non-neuronal cells REST is involved in 
immunity
54
, cardiac function
55
 and cellular proliferation
56
, being also heavily involved in 
cancer development
45
.  
Calderone and collaborators, first reported on the contribution of REST up-regulation (mRNA 
and nuclear protein) to ischemia-induced neuronal cell death
52
,  the mechanisms involved 
repression of glutamate receptor subunit GluR2
52,57
. Subsequent studies revealed that REST 
induction by ischemia, had more pronounced effects on gene expression, leading to the 
epigenetic remodeling and suppression of several neuronal genes, which ultimately lead to 
cell death
53
. Studies using cultured neuroblastoma cell lines, subjected to an in vitro model of 
ischemia, oxygen and glucose deprivation, also exhibited increased REST mRNA and 
protein
58
. These studies were the first to identify a potential link between low oxygen and 
REST regulation (Table 2). Recently it has been shown that REST is a hypoxia-responsive 
transcriptional repressor, acting as a master regulator of gene repression in hypoxia, 
regulating 20% of all hypoxia-repressed genes in HEK293 cells exposed to 1% oxygen
40
. 
Upon exposure to hypoxia, REST accumulates in the nucleus (almost 4-fold increase over 
normoxia at 16 and 24 hours), and this can be rapidly reversed by re-oxygenation, REST 
protein stability was not affected by hypoxia, and REST mRNA was only modestly and 
transiently increased (at 2 hours of hypoxia), suggesting that the main mechanism for REST 
nuclear accumulation involves a nuclear translocation regulated by a post-translational 
regulation mechanism
40
. A recent study by Rios and collaborators, has also reported REST 
accumulation in the nucleus of Marrow-isolated multilineage inducible (MIAMI) cells 
exposed to 3% oxygen for 7 days, with only a very modest <1.5-fold increase in REST 
mRNA.
59
. While the mechanisms responsible for nuclear translocation of REST in hypoxia is 
currently unknown, REST has been shown to require several proteins such as dynactin 
p150(Glued), huntingtin, HAP1, and RILP/Prickle1 to form a complex involved in its the 
translocation into the nucleus
60
.  REST is post-transcriptionally regulated by 
phosphorylation
61,62
 (Casein-kinase II
63
) and ubiquitylation (-TRCP61,62, HAUSP64 and 
DYRK1A
65
), a promising topic to study the regulation of REST in hypoxia, as these post-
translational modifications are used by hypoxia to modulate the activity of several hypoxia 
responsive proteins (e.g. HIF and NFB pathways)66-68. Two studies reported a decrease in 
REST expression, in total cell lysates after 72 hours of 2% oxygen, in prostate cancer LNCaP 
cells
69
, and 5% oxygen in prostate cancer PC-3 cells and neural crest cells
70
. The mechanism 
for REST down-regulation involved hypoxia-induced miR-106b~25
70
. This suggests that 
similarly to the HIF response which is resolved in prolonged hypoxia, to prevent over-
activation of its target genes
71,72
, the REST response to hypoxia also needs to be resolved. In 
summary, several lines of evidence suggest that REST is regulated by oxygen deprivation, in 
both hypoxic cell lines and ischemic rodents (Table 2). 
  
2.2.1-Physiological relevance of REST regulation by hypoxia 
Originally discovered as regulator of neuronal development, REST has since be found to be a 
very versatile and context specific transcription factor
45,73
.  For example, in non-neuronal 
cancers of the breast, lung and colon REST is a tumor suppressor
45,73
, while in neuronal 
cancer REST is an oncogene
73-75
. In the adult brain REST can also play contradictory roles, 
being neurotoxic in ischemia
52,53,57
, epilepsy
50,51
 and  unt ngton’s disease,76,77 and 
neu op ote t ve  n ag ng and Alzhe me ’s d sease44. 
Regarding the role of REST in hypoxia and in oxygen-deprived conditions such as ischemia, 
the roles and genes regulated by REST also point to diverse and cell-type specific roles 
(Table 3). Global ischemia is able to induce REST protein and mRNA in hippocampal 
neurons, REST-epigenetic reprograming and repression of neuronal genes (e.g. GluR2, 
GluA2) leading to cell death
52,53,57
. In HEK293 cell we have showed it contributes to the 
resolution of the HIF-response, and regulates HIF-dependent metabolic adaptation to hypoxia 
(glycolytic genes)
72
. HIF-signaling is also negatively regulated by REST in prostate cancer 
cells
69
. Thus regulation of HIF-signaling is a key feature of REST in hypoxia. 
In a study by Lin and collaborators, REST downregulation after 3 days in hypoxia (2% 
oxygen) was required for the neuroendocrine phenotype of prostate cancer cells exposed to 
hypoxia, namely neuron-like extensions and AMPK activation (phohspho-Thr172)
69
. 
Suggesting that tumor hypoxia in solid prostate cancer down-regulates REST as a mechanism 
to induce the neuroendocrine phenotype, which is observed in the most advanced, treatment-
refractory stages of this cancer
69
. Notably, their comparison of the transcriptomic changes 
induced by REST RNAi in normoxic cells, and cells exposed for 3 days of hypoxia, revealed 
a 20% overlap in the induced genes, suggesting that REST down-regulation in 
prolonged/chronic hypoxia is a mechanism involved in late transcriptional up-regulation in 
hypoxia
69
.  
REST is overexpressed in neuronal cancers, and has oncogeneic properties, it inhibits 
apoptosis and promotes tumorigenisis
74,75
. Interestingly, hypoxic neuroblastoma tumors and 
cells exposed to hypoxia (1% oxygen) down-regulate neuronal markers
78,79
, and REST protein 
is induced in oxygen/glucose deprived SK-N-SH neuroblastoma cells58. Thus, it is plausible 
that REST induction by the hypoxic microenvironment known to be present in neuronal 
tumours
80
, contributes to its oncogenic role. Interestingly our RNA-seq analysis revealed 
REST dependent repression of cell adhesion genes, which might be important for metastasis 
as hypoxic suppression of adhesion molecules allows cancer cells to escape their stressed 
environment
81,82
. Several of the REST target genes we identified in our RNA-seq analysis 
where part of cancer pathways (RB1, MET, MYCBP, WNT5A, HDAC1, PRKCB, LAM4A, 
LAMC1 and LAMB1). HIF itself is implicated in cancer, and has been show to be repressed 
by REST in HEK293
72
 and prostate cancer cells
69
. The physiological relevance of REST 
regulation of all these cancer-related genes in hypoxia, beyond the in vitro cell culture 
paradigm, will most certainty be context- and cell- type specific as REST is well known to 
play both tumor suppressor and oncogenic roles, a feature it shares with NOTCH signalling
83
, 
E-cadherin
84
 and MYC
85
. Overall, existing evidence suggest that the regulation of REST 
protein expression levels by hypoxia in cancer cells, both its induction in neuronal cancer and 
its down-regulation in prostate cancer, plays an pathogenic role. 
During neuronal development, neuronal stem cells require REST down-regulation for the 
expression of neuron-specific genes
42
. Hypoxia is well known to be a signal required for 
proper embryonic development
3
, and is reported to promote neuronal development through an 
unknown mechanism
86
. Using neural crest cells as a model to study neuronal development, 
Liang and collaborators showed that hypoxia promotes REST down-regulation through up-
regulation of miR-106b~25
70
. Hypoxia and REST RNAi treated cells induced to a similar 
level the expression of several neuronal markers: the transcription factor ASH-1, the 
downstream protein paired-like homeobox 2a (Phox2a), and tyrosine hydroxylase (TH)
70
. 
Overall, this study suggest that hypoxic down-regulation of REST in neuronal precursor cells, 
is an important mechanism for neuronal development.  
We recently published a deep analysis of the effect of REST on hypoxia regulated gene 
repression, we analyzed the transcriptomic changes by RNAseq, and found that REST RNAi 
rescued the hypoxic repression of 201 genes, 20% of the total hypoxia repressed genes
40
. 
Thus we showed for the first time that REST is a master regulator of gene repression in 
hypoxia. Gene ontology analysis of the REST-repressed genes in hypoxia suggests that REST 
plays an important role in the cellular adaptation to hypoxia by suppressing genes involved in 
proliferation, cell cycle progression and transcription
40
. Our own ChIP experiments confirmed 
the hypoxic regulation of SYJN1 encoding synaptojanin 1, a protein involved in clathrin-
mediated endocytosis and ATP-intensive process
40
. Thus repressing energy demanding 
processes in hypoxia is a plausible function for REST.   
As discussed above, REST regulates HIF and HIF-signalling
59,72
, including HIF-target genes 
involved in glucose metabolism
72
, biosynthesis of lipids and nucleic acids, and protein 
catabolism
40
. Thus, REST seems to be heavily involved in the regulation of the metabolism of 
hypoxic cells. 
 
2.2.2-Mechanism of REST-mediated gene repression in hypoxia 
 In ischemic neurons, REST is recruited to the promoter of MOR-1
57
 and GluA2
53
, as assessed 
by Chromatin immunopreceptitation assays. Furthermore, GluA2 promoter exhibited 
recruitment of the REST co-repressor complexes CoREST and mSin3, and marks of 
epigenetic silencing, that where dependent on REST
53
. CoREST and mSin3 are multiprotein 
co-repressor complexes that contain both chromatin remodelers (BRG1, SWI/SNF) and 
histone modifiers (histone deacetylases 1 and 2, histone methyl-transferase G9a)
42
 This 
suggests that REST recruitment, with co-repressor complex assembly and epigenetic silencing 
is a mechanism for hypoxic gene repression. 
 
In hypoxic HEK293 cells, we have observed REST recruitment to the HIF-172 and SYNJ140 
promoters, with co-repressor complex components CoREST and mSin3 also being recruited 
to the HIF-1 promoter72. Interestingly, the GANAB gene had REST bound to the promoter 
in hypoxia, but there was no increase of REST binding with hypoxia compared to control 
cells (21% oxygen)
40
. Despite the absence of REST recruitment, GANAB was regulated by 
REST in hypoxia, as assessed by rescue of GANAB repression in hypoxia by REST RNAi
40
. 
Thus, we propose that, while REST recruitment is required for transcriptional repression of 
some genes (e.g. SYNJ1, HIF-1), for other genes (e.g. GANAB) REST might already be 
bound to its target gene in normoxia in a low affinity state, “po sed to a t ” w th  ts  ep ess ve 
activity triggered only in hypoxia, possibly by co-factor recruitment
40
. 
This hypothesis finds support in studies by Otto and colleagues
87
, where many of REST-
occupied genes were still expressed while others were repressed, potentially due to their 
functional relevance to the cell.  
Using publically available REST ChIP-seq datasets we found that 64% of our identified 
normoxic REST target genes and 18% of our hypoxic REST target genes were previously 
described in these datasets
40
. This suggests that in hypoxia, REST regulates more genes 
indirectly than by direct binding. Consistent with indirect regulation we found that REST 
repressed the expression of transcription factors and transcriptional machinery in hypoxia
40
.  
In conclusion, 3 potential mechanisms account for REST mediated gene repression in 
hypoxia, direct REST recruitment to the gene promoter, activation of REST activity in genes 
whe e       s “po sed-to-a t”  and  nd  e t me han sms. 
 
3- Other hypoxia responsive transcriptional repressors 
 
3.1 DEC1 and DEC2 
DEC1 (Differentially expressed in chondrocytes protein 1) was found to be inducible by 
hypoxia in a screen for factors dependent on the VHL- HIF pathway, and its expression is 
dependent on HIF-1α  as  ells la   ng  un t onal  I 1α do not up-regulate DEC1 in response 
to hypoxia
88
. The role of DEC1 activation in hypoxia is best described in melanocytes, where 
HIF-1α  ndu ed D  1  s  e  u ted to the M-MTIF promoter (melanocyte-specific isoform of 
the microphthalmia-associated transcription factor) and represses its transcription, resulting in 
an inhibition of the oncogenic properties of M-MITF (the)
89
. 
Tumor hypoxia down regulates key genes of the DNA mismatch repair system, leading to 
genomic instability and tumor progression. A study in multiple cancer cell lines, has shown 
that hypoxic repression of the key mismatch repair gene (MLH1) is transcriptionally 
regulated by DEC1 and DEC2, which are induced by HIF-1α  n hypoxia 89-91. 
 
3.2 Bach1 
The transcription repressor Bach1 (BTB and CNC homology 1, basic leucine zipper 
transcription factor 1), is transcriptionally induced by hypoxia in several human cell lines, and 
to promotes transcriptional repression of HO-1 (heme oxygenase-1). The physiological 
relevance of this mechanism is not known. HO-1 is induced by and promotes degradation of 
heme, in a protective response against oxidative stresses
108
. 
 
3.3 ID1 and ID2 
The protein inhibitor of DNA binding 2 (ID2), while not being a transcriptional repressor, is a 
negative regulator of the activity of bHLH transcription factors
78
. ID2 is involved in normal 
neural crest development and inhibits pro-neuronal bHLH proteins. Hypoxia leads to a 
reduction of neuronal gene expression in neuroblastoma, and ID2 mRNA is quickly induced 
(3-fold after 2 hours) in SK-N-BE(2) neuroblastoma cell lines, and transcriptionally 
dependent on HIF-1α78. Hypoxic induction of ID2 may contribute to the neuroblastoma de-
differentiation into a neuronal crest-like phenotype (loss of neuronal markers) associated with 
increased tumor growth and aggressiveness
78
. ID1 is also induced by hypoxia in multiple cell 
types, but with unreported function
78,92
. 
 
3.4 ZEB1/ZEB2  
E-cadherin loss of function is a hallmark of metastatic cancer. Renal clear cell carcinoma 
(RCC) is characterized by loss of function of the von Hippel-Lindau tumor suppressor (VHL), 
which negatively regulates (HIF-1)93. Loss of E-cadherin expression in VHL-null RCC4 
cells can be corrected by rescue of VHL expression, or inhibition of HIF-1 using a dominant 
negative mutant or RNAi
93
. Because the mRNA expression of ZEB1 and ZEB2, well-
described transcriptional repressors of E-cadherin, where reduced upon HIF inhibition, the 
authors suggest that loss of E-Cadherin in Renal clear cell carcinoma is due to HIF-dependent 
induction of ZEB1/ZEB2.
93
 
 
3.5 Snail 
Snail, like ZEB1 and ZEB2, is a well-described transcriptional repressor of E-Cadherin. Studies in 
ovarian cancer cell lines have shown that Snail mRNA in induced by hypoxia, suggesting it might 
contribute to hypoxia induced epithelial mesenchimal transition and metastasis in ovarian cancer by 
repressing E-cadherin.
94 
 
3.6 CtBP 
The transcriptional corepressor C-terminal-binding protein (CtBP) is able to sense free 
nuclear NADH and transduce this into changes in gene expression
42
. In cancer cell lines, 
hypoxia increased free NADH levels, promoting CtBP recruitment to the E-cadherin 
promoter. In addition, hypoxic repression of E-cadherin and increased cell migration, where 
rescued with CtBP RNAi
95
. Thus, hypoxic recruitment of CtBP to the E-Cadherin promoter is 
a mechanism for E-Cadherin repression and increased cancer cell migration in hypoxia. 
 
3.7-HIF-dependent gene repression  
Microarray data combined with siRNA against HIF-1/-2 indicate that there are HIF-
dependent and HIF-independent hypoxia repressed genes
31
. For example, EIF5A is 6-fold 
repressed in hypoxia, but only 1.5-fold repressed in the presence of HIF-2 siRNA
31
. While 
there are some cases of hypoxic gene repression by HIF binding to gene promoters (e.g. 
CFTR
96
, ADK51
97
 and APC
98
), these seem to be the exception rather than the rule, as studies 
combining genome wide ChIP-seq and microarray data indicate that while HIF is enriched in 
the promoters of genes induced in a HIF-dependent way, it is not enriched in the promoters of 
genes that are repressed in hypoxia, thus indicating the presence of HIF-independent and/or 
indirect HIF-dependent mechanisms governing gene repression in hypoxia
99
.  Supporting this 
notion, transcriptional regulation in hypoxia exhibits temporal waves of regulation, with a 
second late wave of transcriptional regulation by transcription factors that were 
transcriptionally induced by hypoxia in the first early wave of regulation
66
.  
 
3.8-Hydroxylase dependent gene repression 
Some studies have revealed that hypoxia repressed genes can also be repressed by DMOG, a 
2-oxoglutarate analogue, commonly used as a “hypox a m met  ” d ug that a t vates  I  
through the inhibition of the Prolyl hydroxylase domain containing (PHD) enzymes. An 
example is the DNA repair gene BRCA2, in hypoxic breast cancer cells
100
. Transcriptomic 
studies comparing the effect of hypoxia and DMOG, revealed a sticking overlap, with 77% of 
the hypoxia induced genes also induced by DMOG
31
. This is consistent with the perceived 
central role of PHD/HIF in hypoxia induced gene expression
26
. When the effects on hypoxia 
repressed genes where analyzed, the overlap was 36%
31
. This suggests that the PHD/HIF 
pathway does not play such a predominant role in gene repression as it does in gene 
induction. In addition, PHD and other 2-oxoglutarate-dependent enzymes could contribute to 
gene repression in hypoxia, possibly thought the hydroxylation of transcriptional repressors. 
This exciting hypothesis remains to be tested.  
Another class of hydroxylases that can play a role in gene repression in hypoxia are the jmjC 
demthylases, reviewed in
101
. These hydroxylases require molecular oxygen to de-methylate 
histones, leading to epigenetic silencing. Interestingly, more than twenty jmjC demethylases 
have been shown to be induced by hypoxia / HIF, thus raising the possibility that they 
contribute to gene repression in hypoxia through epigenetic silencing mechanisms
101
.  
Thus, while the underlying mechanisms are only recently being explored, hydroxylases might 
play a role in gene repression in hypoxia. 
 
 
4-Cross-talk between REST and HIF: master regulators of gene repression in hypoxia 
As mentioned above, REST negatively regulates HIF-expression and HIF-signaling in 
HEK293
72
 and MIAMI
59
 cells. Other reports in the literature suggest that REST and HIF 
cross-talk to fine tune target gene expression. Namely, the NCX1 gene (Na
+
/Ca
2+
 exchanger 
1), coding for a plasma membrane protein regulating intracellular calcium and sodium 
homeostasis in the brain, is epigenetically repressed in a rat model of brain ischemia by the 
REST/Sp3 complex and induced in brain ischemic preconditioning by the HIF-1/Sp1 
complex
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. Thus, in addition to regulating specific cohorts of hypoxia induced and hypoxia 
repressed genes, HIF and REST, share some transcriptional targets, working together to fine-
tune the transcriptional response to hypoxic challenges.  
 
 
5-Conclusions 
Cellular adaptation to hypoxia involves multiple responses ranging from changes in the 
activity of pre-existing proteins, inhibition of protein synthesis, and also modulation of the 
transcriptional landscape (Figure 1). Our understanding of the mediators of transcriptional 
changes in hypoxia is rapidly expanding. While HIF has earned and deserves to  eta n  t’s 
place as the master regulator of gene induction in hypoxia, evidence also exists for at least 20 
other transcriptional activators in hypoxia (Table S1). Transcriptional repression in hypoxia, 
on the other hand, is less well understood. We now know that at least 10 transcriptional 
repressors are regulated by hypoxia (Table 1). Most of these factors have been identified to 
regulate cancer related genes M-MTIF, MLH1 and E-Cadherin, and to contribute to hypoxic 
modulation of cancer cell metastasis and DNA mismatch repair response (Figure 2). For most 
transcriptional repressors (DEC1, DEC2, ID1, ID2, ZEB1, ZEB2, Snail, Bach1, REST) 
hypoxia regulates their expression (protein or mRNA level) using HIF-dependent and 
independent mechanisms (Figure 2). In the case of DEC1, CtBP and REST, hypoxia also 
seems to promote their recruitment to the promoter of its target genes (Figure 2). REST is 
undoubtedly the most studied and best understood transcriptional repressor in contexts of 
oxygen deprivation, including hypoxic exposure of cell lines in vitro and ischemia in rodents. 
REST induction by oxygen deprivation plays a pathogenic role in ischemic neurons and 
oxygen/glucose deprived neuroblastoma cells (Table 2), where REST-repression of neuronal 
genes contributes to cell death (CART, MOR-1, GluR2, GluA2). In addition to these genes, 
REST is recruited to the promoter of 12 other genes in ischemic neurons, the relevance of 
which is unknown (Table 3). In HEK293 cells and MIAMI cells, REST regulates HIF 
signaling, promoting resolution of the HIF-1 response, which can be damaging when over-
activated
33-36
. Another mechanisms for REST-mediated gene regulation in hypoxia, is 
repression of REST protein and subsequent de-repression (induction) of target genes. This 
mechanisms seems to play a role in the neuroendocrine and neuronal differentiation of 
prostate cancer cells and neuronal crest cells, respectively (Table 3). However, evidence is 
lacking for this mechanism, as no gene was yet identified as induced by hypoxia in a REST-
dependent manner using genetic modulation of REST expression. The most common 
mechanism for REST regulation of gene expression in hypoxia, seems to rely on the 
induction of REST expression (mRNA and/or protein), nuclear accumulation and recruitment 
to the target gene (as accessed by Chromatin immunoprecepitation assays). Several genes 
have been identified in which REST inhibition (RNAi or dominant negative REST 
expression) rescues their repression in hypoxia (Table 3). These include HIF-1, with effects 
on glycolytic metabolism and the neuronal genes CART, MOR-1, GluA2, GluR2, with effects 
on neuronal cell death. Other genes validated to be REST-repressed in hypoxia include 
GANAB, RAB3C, and SYNJ1, the last one being involved in endocytic processes and energy 
demanding process, suggesting that REST might contribute to the transcriptional repression 
of energy-demanding processes in hypoxia. This is further substantiated by our recent 
transcriptomics (RNAseq) analysis, where we found that REST RNAi rescued the hypoxic 
repression of 201 genes, including genes involved in energy demanding processes such as 
transcription, metabolism, proliferation and cell cycle progression.  
The hypoxia-repressed transcriptomic signature of cancer cells has prognostic value in 
cancer
37
. Expanding our understanding of the mechanisms of gene repression in hypoxia will 
open new avenues for developing diagnostic, prognostic and potentially therapeutic 
approaches. REST inhibitors are already being developed for the treatment of nuerological 
disorders, where REST plays a pathogenic role
103
. These are expected to be useful in situation 
where inhibiting REST activity in hypoxia might be beneficial, for example, REST 
contributes to neuronal cell death in ischemic neurons, thus its inhibition is predicted to be 
beneficial in ischemic diseases (e.g. stroke). 
We are only starting to unravel the physiological relevance and the mechanisms of gene 
repression in hypoxia. The transcriptional repressor REST, seems to play a prominent role in 
gene repression in hypoxia, it is the most studied and best described repressor, and can 
regulate up to 20 % of hypoxia repressed genes
40
. Thus, REST is the first master regulator of 
gene repression in hypoxia. 
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Figure 1. Molecular mechanisms of adaptation to hypoxia. Adaptation to hypoxia involves 
3 major responses: increased glycolysis to cope with ATP depletion, increased oxygen 
delivery to restore oxidative phosphorylation, and inhibition of energy-demanding processes, 
to direct the scarce energetic resources to key house-keeping functions. This can be achieved 
by acute responses that rely on the modification of pre-existing proteins (e.g. AMPK and HO-
2), translational inhibition (mediated by mTOR and PERK) and transcriptional changes 
(mediated by HIF and largely unknown mechanisms for transcriptional repression). Depicted 
are examples of these mechanisms (from left to right): (1) Hypoxia decreases ATP production 
(energetic stress), this activates AMPK that restores energetic homeostasis by inducing 
catabolic pathways and inhibiting anabolic pathways. Adapted from
104,105
. (2) Haem 
oxygenase-2 (HO-2)-generated carbon monoxide (CO) is reduced under hypoxia, CO inhibits 
cystathionine-γ-lyase (CSE)-regulated hydrogen sulfide generation, thus in hypoxia more 
H2S is generated, inhibiting potassium channels (K+ channel), this leads to increased Ca2+ 
influx through Ca2+ channels, which initiates neuronal signaling to the central nervous 
system, ultimately increasing the rate and depth of breathing. Abbreviations: NT, 
neurotransmitter(s); and NT-R, neurotransmitter receptor. Adapted from
15
. (3) Hypoxia 
activates TSC1/2 via AMPK or HIF-1α/  DD1     1/   nh b ts m O  lead ng to an 
inhibition of 4EBP1, a negative regulator of the eIF4E, thus suppressing protein translation. 
mTOR also activates P70S6K, which activates ribosomal protein S6. Adapted from
23,106,107
. 
(4) Alternatively hypoxia can activate the effector of the UPR, the kinase PERK, which 
phosphorylates and inactivates eIF- α  thus lead ng to supp ess on o  p ote n t anslat on. 
Adapted from
23,106,107
. (5) HIF is the master regulator of gene induction in hypoxia. HIF is 
stabilized by inhibition of the oxygen-dependent PHD enzymes. (6) Transcriptional 
repression is an essential component of adaptation to hypoxia through the inhibition of energy 
demanding process. However, the mechanisms for transcriptional gene repression in hypoxia 
are poorly understood.     
 
Figure 2. The landscape of transcriptional repressors in hypoxia. Depicted are the known 
hypoxia-regulated transcriptional repressors, their target genes and the biological processes 
they regulate in hypoxia (see text for details). For most transcriptional repressors (DEC1, 
DEC2, ID1, ID2, ZEB1, ZEB2, Snail, Bach1, REST) hypoxia regulates their expression 
(protein or mRNA level) using HIF-dependent and independent mechanisms. In the case of 
DEC1, CtBP and REST, hypoxia also seems to promote their recruitment to the promoter of 
its target genes. REST is the best-described transcriptional repressor in hypoxia. The most 
common mechanism for REST regulation of gene expression in hypoxia, seems to rely on the 
induction of REST expression (mRNa and/or protein), nuclear accumulation and recruitment 
to the target gene. At least 9 genes are regulated by REST in hypoxia, these where validated 
using chromatin immunoprecepitation assays to show REST recruitment to their promoters, 
and REST RNAi to rescue their hypoxic repression. 
  
Table 1. Hypoxia responsive transcription repressors 
Name         Description  
DEC1/2 Induced by HIF-1 in hypoxia, repress MITF and MLH1 
89-91
 
BACH1 Induced by hypoxia, represses HO-1 (haem oxygenase-1) 
108
 
ID2 Induced by hypoxia, HIF-1 dependent, may contribute to hypoxic neuroblastoma de-
differentiation into a neuronal crest-like phenotype. 
78
 
ID1 Induced by hypoxia in multiple cell types. 
78,92
 
ZEB1 / 
ZEB2 
Repressed in RCC4 cells in response to dn-HIF-1α o  V L ove exp ess on  but may 
be repressed by hypoxia. Known repressors of E-cadherin. 
93
 
SNAIL Induced by hypoxia in ovarian cancer, may contribute to hypoxia induced 
EMT/metastasis by repressing E-cadherin. 
94
 
REST Induced by hypoxia and ischaemia, it represses multile genes in hypoxia, including 
HIF-1. See Table 2 and 3 for details. 
CtBP This co-repressor is be recruited to the E-cadherin promoter, in response to increased 
NADH levels in hypoxia.
95
 
 
Table 2. REST regulation in oxygen-dprived conditions 
Experimntal condition  Effect on REST  Function Ref 
Ischemic neurons 
( a)
 mRNA  
nuclear protein 
Represses gluR2 leading to 
neuron death 
52,57
 
Ischemic neurons
 (a)
  mRNA 
nuclear protein 
Epigentic remodelling and 
repression of neuronal genes 
53
 
Oxygen/glucose deprived SK-
N-SH cells
(b)
 
mRNA  
protein 
Represses the neuropeptide 
CART leadint to cell death 
58
 
1% O2 (24 hrs), HEK293 cells  nuclear protein Represses >200 genes 
40
 
3% O2 (7 days),  
MIAMI cells 
 mRNA 
 nuclear protein 
Hypoxia-induced stem cell self-
renewall  
59 
2% O2 (3 days), 
LNCaP cells
(c)
 
 total protein 
mRNA not affected 
Neuroendocrine phenotype of 
prostate cancer cells (AMPK 
activation, neurite growth) 
69
 
5% O2 (3 days), 
LNCaP, PC-3 cells
(c)
 
 
 total protein 
 tmRNA 
Neuroendocrine phenotype of 
prostate cancer cells  
 
70
 
5% O2 (3 days), 
primary neural crest cells 
 total protein 
 tmRNA 
Neuronal diferentiation of 
neural crest cells 
70
 
Notes and abbreviations: (a) Studies performed on hypocampal CA1 neurons from  mouse model of ischaemia; (b) 
SK-N-SH cells are a neuroblastoma-derived cell line; (c) LNCaP and PC-3 are prostate cancer derived cell lines. 
 
Table 3. REST target genes in oxygen-deprived conditions 
Experiment  Target  Evidence Ref 
Ischemic neurons 
( a)
 GluR2 REST RNAi rescues ischemic repression  
Western Blott and Immunoflurescence 
52
 
Ischemic neurons 
( a)
 MOR-1 Ischaemia promotes REST recruitment to the 
promoter
 (b) 
Chromatin-Immunoprecepitation 
57
 
Ischemic neurons
 (a)
 GluA2 Ischaemia promotes REST recruitment to the 
promoter
 
and epigenetic silencing  
Chromatin-Immunoprecepitation 
 
REST RNAi or dnREST
(c)
 rescues ischemic 
repression  
WesternBlott and qRT-PCR  
53
 
Ischemic neurons
 (a)
 Peg12 
Slc22a12 
  κb  
GluA2 
Chrnb2 
Grin1 
Csrnp3 
Nppa 
Slc22a13S
cg2 
Fdxr  
Nefh 
Syp 
Ischemia (24 and 48 hours) promotes REST 
recruitment to the promoter
(d) 
ChIP-on-chip 
53
 
OGD, SK-N-SH
(e)
 CART REST RNAi rescues hypoxic repression  
qRT-PCR 
58
 
1% O2, HEK293 Hif-1 REST RNAi increases expression and activity 
in hypoxia 
WesternBlott and qRT-PCR 
 
Hypoxia promotes REST recruitment to the 
promoter 
Chromatin-Immunoprecepitation 
72
 
1% O2, HEK293 201 genes 
 
 
GANAB 
SYNJ1 
 
 
 
GANAB 
CYP1B1 
RAB3C 
REST RNAi rescues hypoxic repression  
RNA-seq 
 
REST is enriched in the promoter 
Hypoxia promotes REST recruitment to the 
promoter 
Chromatin-Immunoprecepitation 
 
REST RNAi rescues hypoxic repression  
qRT-PCR 
 
40
 
2% O2 ,LNCaP 
 
AMPK REST RNAi increases AMPK activation  
WesternBlott 
69
 
Notes and abbreviations: 
(a)
 Studies performed on hypocampal CA1 neurons from  mouse model of 
ischaemia; 
(b)
 MOR-1 is a well known REST target gene, that is repressed in ischaemia
57
; 
(c)
 dominat 
negative REST; 
(d)
 58 targets at 24 hrs, 50 targets at 48 hrs; 
(e)
OGD, oxygen/glucose deprivation. 
 
 
Highlights: 
 Gene repression accounts for approximately 50% of the transcriptional 
response to hypoxia. 
 A number of transcriptional repressors have been identified as hypoxia-
sensitive. 
 REST is a key transcriptional repressor in hypoxia 
 
